No trial has ever tested diet alone for perimenopause

Perimenopause, the transition years before menopause, brings a wide mix of physical and psychological symptoms that can affect health, well-being and quality of life. Lifestyle changes such as exercise, dietary adjustment and health education are frequently suggested as first steps for managing those symptoms, yet the evidence behind that advice has been inconsistent. This review set out to gather every randomised controlled trial of lifestyle interventions for perimenopausal symptoms, synthesise what they show and identify where the gaps are. For a life stage that affects half the population, the state of that evidence matters.

Following the PRISMA guidelines for systematic reviews, the authors searched four electronic databases: PubMed, CENTRAL, Web of Science and Scopus. Two reviewers independently screened records for eligibility, extracted the data and rated study quality using a modified Downs and Black checklist alongside a structured evidence-grading strategy. Twenty-five randomised controlled trials met the inclusion criteria. Nine tested exercise-only interventions, 12 tested combined interventions and five tested health education alone.

The pooled picture suggests both exercise and health education might offer benefits for managing perimenopausal symptoms. But the trials varied enormously between studies, and those methodological inconsistencies mean the review could not produce evidence-based guidelines for lifestyle prescription during perimenopause. Perhaps the most striking result was an absence: not one of the 25 trials exclusively examined a diet-based intervention. The authors conclude that further high-quality research is needed to determine the optimal principles of lifestyle prescription for this stage of life.

Menopause research has grown rapidly, but this review shows perimenopause specifically remains poorly served by rigorous trials, and the diet gap is a genuine hole in the literature rather than an oversight of the search. Promising signals sit on top of methodologically inconsistent studies, so guidance currently rests more on plausibility than proof. Until trials converge on comparable designs and outcome measures, that will not change. The review's clearest contribution is a research agenda: higher quality trials, and someone finally testing diet on its own.

If you are navigating perimenopause, the honest reading is that exercise and structured health education have supportive, if imperfect, trial evidence behind them for symptom management. Dietary changes may well help too, but no randomised trial has tested diet by itself in this group, so any specific dietary claim aimed at perimenopausal symptoms currently runs ahead of the evidence. That is worth knowing when weighing the products and programmes marketed at this life stage.